The number of patents filed by China has accelerated over the last 15 years. According to WIPO, China represented just 1 percent of the fillings with the PCT in 2000. By 2015, China’s share of PCT filing was 13.7 percent. We were interested to see how this increase in patent fillings related to China’s growth in GDP.
UPDATED:
Here is a link to the recording of the seminar. Please see Professor Outterson’s slideshow for more detail and explanation.
Original
Continue Reading
UPDATED:
Here is a link to the recording of the seminar. Please see Bhaven’s slideshow for more detail and explanation.
Original
Continue Reading
Leaked text can be found here.
On 9 October 2015, Wikileaks released the final text of the IP chapter in the Trans-Pacific Partnership. Jamie Love provided comments via twitter.
https://twitter.com/jamie_love
Updated: 9 October 2015
(In the order posted)
UPDATED:
Here is a link to the recording of the seminar. Please see Aidan’s paper and slideshow for more detail and explanation.
Original
Continue Reading
Leading up to the release of Professor Joe DiMasi’s latest study of the cost of drug development, KEI offered $50 to the individual who could most accurately predict the new cost for drug R&D.
We received 26 guesses, ranging from $1.157 billion to $5 billion.
Joel Lexchin’s estimate ($2.47 billion) was the closest to DiMasi’s number ($2.558 billion). It was also the 5th largest estimate.
A complete list of submissions is below.
Name & Guess
Charles Clift – 1.157 billion
Nicole H – 1.2 billion
Ronald Rader – 1.55 billion
Wouter Deelder – 1.655 billion
Continue Reading
On September 17, the House Judiciary marked up H.R. 5233, “The Trade Secret Protection Act of 2014.” The bill would create a civil right on action in federal courts for misappropriation of trade secrets, as defined in the bill. [Link to hearing, bill and transcript of markup]. Continue Reading
This is a note on Gilead run or funded programs that are available for patients residing in the United States.
Recently, Gilead’s new hepatitis C drug, Sovaldi, has received much attention and criticism for its high price of $1000 a day.